Picture of Adjuvant Holdings logo

4929 — Adjuvant Holdings News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesConservativeMicro CapNeutral

Table: Adjuvant Cosme Japan -2015/16 group results

Apr 22 (Reuters)-  
          Adjuvant Cosme Japan Co., Ltd.  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to       NEXT    
                Mar 20, 2016    Mar 20, 2015   Mar 20, 2017     YEAR      
                   LATEST         YEAR-AGO        COMPANY      COMPANY    
                   RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales             4.40            4.50           5.14          2.47     
                 (-2.3 pct)      (-1.5 pct)     (+16.7 pct)  (+13.3 pct)  
  Operating        647 mln         733 mln        768 mln      380 mln    
                 (-11.8 pct)     (-26.8 pct)    (+18.8 pct)   (+5.3 pct)  
  Recurring        707 mln         759 mln        769 mln      380 mln    
                 (-6.9 pct)      (-24.7 pct)    (+8.8 pct)   (-10.5 pct)  
  Net              266 mln         47 mln                                 
                (+465.7 pct)     (-91.8 pct)                              
  Net                                             450 mln      222 mln    
                                                (+69.4 pct)  (-10.9 pct)  
  EPS             33.83 yen       6.08 yen       56.62 yen    27.99 yen   
  EPS Diluted     33.44 yen       5.96 yen                                
  Ann Div         24.00 yen       24.00 yen      24.00 yen                
  -Q2 Div            NIL             NIL            NIL                   
  -Q4 Div         24.00 yen       24.00 yen      24.00 yen                
   
  NOTE - Adjuvant Cosme Japan Co., Ltd.. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4929.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Adjuvant Holdings

See all news